<DOC>
	<DOCNO>NCT01365494</DOCNO>
	<brief_summary>This study plan establish non-inferiority Rabipur administer simulated post exposure Zagreb schedule compare Essen schedule , healthy Indian adult subject .</brief_summary>
	<brief_title>Immunogenicity Safety Rabies Vaccine , Administered With Two Different Simulated Post Exposure Schedules</brief_title>
	<detailed_description />
	<mesh_term>Rabies</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>1 . Males females age ≥ 18 year . 2 . Individuals give write consent . 3 . Individuals good health available visit schedule study . 1 . Pregnancy unwillingness practice acceptable contraception . 2 . A history Rabies vaccination . 3 . History allergy egg protein . 4 . Known hypersensitivity neomycin , tetracycline , amphotericinB vaccine component . 5 . A significant acute chronic infectious disease use antibiotic may impact subject 's safety /or immunogenicity Investigators opinion time enrolment . 6 . Body temperature ≥38.0°C ( ≥ 100.4°F ) within 3 day study vaccination . 7 . Treatment antimalarial drug , two month prior study . 8 . Individuals receive vaccine within 28 day prior enrollment . 9 . Subjects receive blood , blood product and/or plasma derivative parenteral immunoglobulin preparation past 12 week . 10 . Any planned surgery study period . 11 . Subjects cancer disorder exclude nonmelanotic skin cancer .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Rabies</keyword>
	<keyword>rabies vaccine</keyword>
	<keyword>post-exposure prophylaxis</keyword>
</DOC>